PATIENT-FOCUSED IMMUNOTHERAPY RESEARCH FOR BLOOD CANCER GRANT AGREEMENTCancer Grant Agreement • May 4th, 2016 • New York
Contract Type FiledMay 4th, 2016 JurisdictionGRANT AGREEMENT (the “Agreement”) is entered into as of [ ] between The Leukemia & Lymphoma Society, Inc. (“LLS”) a New York not-for-profit corporation with an office located at 3 International Drive, Suite 200, Rye Brook, NY 10573 and [ ] (“Sponsoring Institution”), located at [ ] (individually each of LLS and the Sponsoring Institution is a “Party” and collectively they are referred to as the “Parties”).
PATIENT-FOCUSED IMMUNOTHERAPY RESEARCH FOR BLOOD CANCER GRANT AGREEMENTCancer Grant Agreement • April 21st, 2016 • New York
Contract Type FiledApril 21st, 2016 JurisdictionGRANT AGREEMENT (the “Agreement”) is entered into as of [ ] between The Leukemia and Lymphoma Society, Inc. (“LLS”) a New York not-for-profit corporation with an office located at 3 International Drive, Suite 200, Rye Brook, NY 10573 and [ ] (“Sponsoring Institution”), located at [ ] (individually each of LLS and the Sponsoring Institution is a “Party” and collectively they are referred to as the “Parties”).
PATIENT-FOCUSED IMMUNOTHERAPY RESEARCH FOR BLOOD CANCER GRANT AGREEMENTCancer Grant Agreement • February 29th, 2016 • New York
Contract Type FiledFebruary 29th, 2016 JurisdictionGRANT AGREEMENT (the “Agreement”) is entered into as of [ ] between The Leukemia and Lymphoma Society, Inc. (“LLS”) a New York not-for-profit corporation with an office located at 3 International Drive, Suite 200, Rye Brook, NY 10573 and [ ] (“Sponsoring Institution”), located at [ ] (individually each of LLS and the Sponsoring Institution is a “Party” and collectively they are referred to as the “Parties”).